Around 53% of luminal A tumors were low-grade DCIS, while none of the luminal HER2/neu and HER2/neu-enriched types and only 5.3% of triple-negative DCIS were of grade 1. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.